Insiders who reported open-market trades in the last 12 months at the companies Srinivas Akkaraju files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
James B. Tananbaum - $3.63M in ALMS purchases and sales in the last 12 months
Foresite Labs, LLC - $3.63M in ALMS purchases and sales in the last 12 months
Srinivas Akkaraju is a corporate insider, tracked as Director of ALUMIS INC. (ALMS). InsiderAlpha holds 28 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Srinivas Akkaraju submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Srinivas Akkaraju been buying or selling stock?
Recorded transactions: 31 open-market purchases ($70.61M) and 5 open-market sales ($35.40M) across all tracked filings.
Srinivas Akkaraju is Director of ALUMIS INC. (ALMS). 28 SEC Form 4 filings on record going back to 2024, most recently on 10 September 2026. Most recent open-market trade: bought $2.90M of ALMS on 10 September 2026. Lifetime open-market purchases: $70.61M. Lifetime open-market sales: $35.40M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Srinivas Akkaraju.
InsiderAlpha's records for Srinivas Akkaraju go back to 2024: 28 primary Form 4 filings, an average of 9.3 per year. The typical open-market purchase is $2.28M (31 buys totaling $70.61M). The largest single buy on record is $15.00M of MLYS in 2025. Sales side: 5 recorded sales totaling $35.40M, so the filing history runs buy-heavy by dollar value. 3 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
